Cargando…

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer

Human bladder cancer (BCa) is the most common urogenital system malignancy. Patients with BCa have limited treatment efficacy in clinical practice. Novel biomarkers could provide more crucial information conferring to cancer diagnosis, treatment, and prognosis. Here, we aimed to explore and identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Fei, Tang, Qianqian, Wang, Yejinpeng, Wang, Gang, Qian, Kaiyu, Ju, Lingao, Xiao, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685517/ https://www.ncbi.nlm.nih.gov/pubmed/34938313 http://dx.doi.org/10.3389/fgene.2021.758612

Ejemplares similares

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
por: Wang, Yejinpeng, et al.
Publicado: (2019)

DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC
por: Wang, Yejinpeng, et al.
Publicado: (2023)

Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer
por: Luo, Yongwen, et al.
Publicado: (2020)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
por: Qiu, Huaide, et al.
Publicado: (2020)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
por: Cui, Mengjing, et al.
Publicado: (2022)

Development and Validation of a Three-Gene Prognostic Signature Based on Tumor Microenvironment for Gastric Cancer
por: Wang, Qian, et al.
Publicado: (2022)

Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer
por: Zhang, Facai, et al.
Publicado: (2021)

PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells
por: Cheng, Songtao, et al.
Publicado: (2019)

Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer
por: Wu, Yucai, et al.
Publicado: (2020)

Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients
por: Zhao, Erjie, et al.
Publicado: (2020)

An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer
por: Liu, Qing, et al.
Publicado: (2022)

The role and function of PPARγ in bladder cancer
por: Peng, Tianchen, et al.
Publicado: (2020)

Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma
por: Yang, Wenlong, et al.
Publicado: (2022)

Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
por: Zhang, Xiangyu, et al.
Publicado: (2022)

Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas
por: Li, Xinrui, et al.
Publicado: (2022)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
por: Zhang, Lu, et al.
Publicado: (2021)

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021)

Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation
por: Liu, Zijian, et al.
Publicado: (2022)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma
por: Zhou, Xianghong, et al.
Publicado: (2020)

Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer
por: Jiang, Kan, et al.
Publicado: (2022)

Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer
por: Wang, Bofang, et al.
Publicado: (2022)

E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability
por: Xu, Huimin, et al.
Publicado: (2021)

The Prognostic Signature and Potential Target Genes of Six Long Non-coding RNA in Laryngeal Squamous Cell Carcinoma
por: Gong, Shiqi, et al.
Publicado: (2020)

Inhibition of MELK produces potential anti‐tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway
por: Chen, Song, et al.
Publicado: (2019)

Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Development and Validation of a Five-RNA–Based Signature and Identification of Candidate Drugs for Neuroblastoma
por: Zhang, PeiPei, et al.
Publicado: (2021)

Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer
por: Pei, Jianying, et al.
Publicado: (2020)

Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer
por: Dong, Bingqi, et al.
Publicado: (2021)

Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma
por: Jin, Yi, et al.
Publicado: (2022)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer
por: Li, Xianzhe, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation
por: Chen, Siming, et al.
Publicado: (2021)

Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas
por: Sun, Penggang, et al.
Publicado: (2023)

Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer
por: He, Yang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jvgt2su79p5am2bodlhm3b14bc